The Ectopic Adrenocorticotrophic Hormone (ACTH) Syndrome (EAS) is a high mortality paraneoplastic syndrome, which represents 10-15% of Cushing Syndromes (CS). Around 70% of tumors are located in the chest, neck or adrenals. It frequently has atypical manifestations, leading to delay in diagnosis. Here, we report a particular case of EAS manifested predominantly by nephrogenic diabetes insipidus (NDI). A 48 years old man, HIV infected, was admitted with polyuria, polidipsia and lower limb weakness. He had hipertension, crackles in the right hemithorax and linphanedophathy. Laboratory assessments showed hyperglycemia, hypernatremia, severe hypocalemia, metabolic alkalosis and low urinary osmolarity, which persisted after water deprivation test and desmopressin administration, characterizing a NDI. Chest images showed a lung tumor, which, in conjunction with the clinical and laboratorial picture lead to the suspicion of EAS. Cortisol levels after dexametasona were 143μg/dL and serum ACTH was 630pg/ mL. Pituitary was normal and adrenals showed bilateral hyperplasia. Lymph node biopsy revealed a neuroendocrine tumor with positive immunohistochemistry for ACTH. Patient died a few days later due to nosocomial pneumonia. The EAS can be associated with very high cortisol levels, which evolves rapidly, resulting in the absence of typical features of CS. The knowledge of the different clinical presentations is essential to establish prompt diagnostic and support. This syndrome has to be considered in patients with a neoplasm and diabetes insipidus, especially if accompanied by signs of excess of mineralocorticoid action. Although the ideal treatment is excision of the tumor, adrenolitic drugs may help to reduce complications and improve survival.
Introduction
The Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome (EAS) is a high mortality paraneoplastic condition characterized by a severe hypercortisolism state induced by ectopic secretion of ACTH. It represents around 20% of ACTH-dependent and 10% of all types of Cushing's Syndrome (CS) [1, 2] .
More than a half of tumors are located in the lungs or thymus and 70% can be found in the chest, neck or adrenals. The most frequent tumors involved are small cell lung carcinoma, carcinoid tumors of the lung, thymus and pancreas, medullary thyroid carcinoma, pancreatic islet cell and pheochromocytoma. Nevertheless, in 12-37.5% of cases, the source of ectopic ACTH secretion remains unknown [1] [2] [3] .
The clinical presentation is heterogeneous and appears to be related to the degree of hypercortisolism, varying from typical CS symptoms and signs (such as central obesity, moon-like face and violaceous striae) to an unusual or atypical picture with aldosterone-like effects, psychiatric manifestations, weight loss, polyuria, skin pigmentation, ankle edema, osteoporosis, aortic dissection and infections [1, 2, [4] [5] [6] [7] .
The state of severe hypercortisolism is responsible for important metabolic and cardiovascular complications, contributing to reduce the quality-of-life and to increased mortality, beyond the oncologic outcomes [7] . Thereby, the knowledge of the different clinical presentations of this syndrome is important to establish a prompt diagnostic and provide an adequate clinical support to these patients.
In this article, we describe a case of EAS associated to lung cancer in a HIV infected man, in which the initial manifestation was polyuria and polydipsia secondary to Diabetes Insipidus (DI). Very few cases of DI have been reported in association with EAS, and most of them were linked to intrasellar metastasis of the primary ACTH -producing tumor [4] . In this case, diluted polyuria persisted after vasopressin administration and pituitary image did not show in-filtrative lesions, indicating a nephrogenic form of DI, which is a frequently unknown or forgotten manifestation of severe hypercortisolism.
Case Report Admission
A 48-year-old man, caucasian, smoker for 22 years (1 pack a day), diagnosed with HIV five years ago, regularly using efavirenz, tenofovir and lamivudine, with suppressed viral load and CD4 count of 711 cells/mm 3 , was admitted for the evaluation of a 3-week history of abrupt onset of severe polyuria, polydipsia, nocturia and lower limb weakness. After inquiring, the patient complained of a frequent productive cough in the last month, without fever, sweats, chills or weight loss. There was no previous medical history of kidney disease, hypertension or diabetes mellitus.
On admission, he was 175 cm high, and weighted 61 Kg (body mass index of 20 kg/m 2 ), appeared well-hydrated, ruddy, anicteric, acyanotic, eupneic and afebrile. There was a mild facial and bilateral ankle edema, normal distribution of fatty tissue and no skin abnormalities, such as striae or hyperpigmentation and right axillary and supraclavicular lymph node of 2cm. Cardiovascular examination showed high blood pressure (160/100 mmHg) and lung auscultation revealed sparse crackles and wheezing in the right hemithorax. Abdominal examination was unremarkable and neurological analysis displayed proximal and distal weakness (3/5) of lower limbs musculature with discrete hypotrophy.
Initial laboratory assessments ( Table 1 and 2) showed severe hypokalemia and metabolic alkalosis, hypernatremia, high blood glucose, normal urinary chloride, high serum osmolality, low urinary density and mild glycosuria. Chest radiograph showed a nodular opacity image at the level of the middle third of the right lung ( Figure 1A ).
Follow-up and clinical diagnosis
During hospital internment, urinary output ranged from 6 to 9 liters, despite of serum glucose control and absence of glycosuria, excluding the possibility of polyuria to be secondary to glycosuria. Plasma osmolality mostly remained above 295 mOsm/L and urinary osmolarity around 240 mOsm/L. During a water deprivation test and intranasal vasopressin administration, the urine density remained persistently low and the sodium serum levels increased, (Figure 2A ). Refractory renal hypokalemia (excretion fraction of 33% and transtubular potassium gradient of 10) was present in the most of the time despite of potassium intravenous replacement and 100 mg of spironolactone, questioning this causal factor on NDI. Nevertheless, we found no correlation between potassium levels and urinary volume (Figure 2B). The NDI secondary to tenofovir was also hypothesized, however, despite the discontinuation of this drug, the patient persisted with high daily diluted urine volume, as high as 6-8L/day.
In front of a renal kypokalemia associated with chlroride-resistant metabolic alkalosis (urinary chlroride of 84 mmoL/L) and hypertension, excess of mineralocorticoids was evoked. Unfortunately, the dosage of aldosterone and renin was not possible. Nevertheless, abdominal computed tomography (CT) scan showed bilateral adrenal hyperplasia (Figure 3). The chest CT exhibited a pulmonary right spiculated nodule of 2.2 cm, in the right upper lobe, associated with mediastinal and hilar lymphadenopathy ( Figure 1B) . In face of this clinical, laboratory and radiological scenario, we hypothesized the possibility of ectopic ACTH secretion. His baseline serum cortisol dosage was 63ug/ml (reference values: 6.2-19.4 ug/ml) and there was no suppression after low-dose dexamethasone test (1 mg overnight: 143μg/dL; 2mg 48h: 63 μg/dL). Magnetic resonance imaging (MRI) of sellar region were normal, except for the absence of the neu-rohypophysis "bright spot", a signal indicative of vasopressin storage (Figure 4) . Serum ACTH was 630pg/ml (reference values: 10 -60 pg/mL). Supraclavicular lymph node biopsy revealed a high-grade neuroendocrine carcinoma (Figure 5A) , with a positive immunohistochemistry for ACTH ( Figure 5B) , which confirmed our hypothesis. He was referred to an oncology center with the purpose of specific chemotherapy treatment, but died a few days later due to nosocomial pneumonia.
Discussion
Ectopic ACTH secretion is a rare manifestation of lung tumors, occurring in 3.2% to 4.5% of cases [4] . It often results in severe hypercortisolemia, which increases the already high morbimortality of the underlying condition. The higher the cortisolemia, the most atypical the manifestation, implying that high levels of perspicacity and knowledge of the possible clinical presentations are needed to establish a prompt diagnosis [1, 2] . Here, we presented a case of EAS in a HIV infected patient, manifested predominantly by NDI, metabolic alkalosis and hypocalemia, which were mistakenly attributed to tenofovir nephrotoxicity and/or hypokalemia at first. Even though the CS caused by EAS has been traditionally associated with atypical manifestations, such as ankle edema, psychiatric disorders and fractures, DI has rarely been included as a possible manifestation of severe hypercortisolemia. Most of the previous reports of the association between EAS and DI were related to the presence of pituitary metastases causing central DI [4] , and only one report described a mixed central and nephrogenic DI [5] . Thus, to our knowledge, this is the first description of purely NDI caused by EAS.
Although frequently forgotten, the association between hypercortisolism and hypotonic polyuria is well established. The pathophysiological mechanisms linking this two endocrine disturbances includes: 1) suppression of vasopressin secretion by hypothalamic feedback action exerted by cortisol [7] [8] [9] ; 2) antagonism of renal vasopressin action [10, 11] ; and 3) impairment of vasopressin action mediated by severe hypokalemia [12, 1, 2, 13] .
Hypokalemia, which is present in up to 70% of EAS cases, is a well-known cause of NDI, and is associated to cyclic AMP system inhibition and downregulation of aquaporin-2 water channel expression in collecting ducts [13, 14] . However, in our case, we found no direct correlation between potassium levels and diuresis. In this scenario, previous studies suggest that polyuria linked to cortisol action is independent of hypokalemia [10, 15] . Besides, other studies have demonstrated that the polyuria is vasopressin resistant, indicating that the primarily involved mechanism is the reduction of water permeability in collecting ducts by impairment of ADH effect [12] .
In this case, the diagnosis of EAS was delayed by the presence of comorbities and the use of multiple drugs, which is a frequent problem in clinical practice. Although the patient had hypertension and hyperglycemia, which are typical finds of Cushing syndrome, those features were initially attributed to HIV infection and lipodystrophy induced by antiretroviral therapy. Hypocalemia and diabetes insipidus, by the other side, were primarily ascribed to tenofovir nephrotoxicity.
Tenofovir is a frequently used antiretroviral drug which has been associated to a pattern of nephrotoxicity characterized mainly by proximal tubule disturbances, which include renal Fanconi syndrome and acute kidney injury in severe cases [16] . Although it can cause NDI in about 12.5% of cases, it is usually associated with kidney injury and metabolic acidosis, in contrast with our patient, who presented chloride resistant metabolic alkalosis and normal kidney function [17, 18] .
In adults, the association of severe hypocalemia, chloride resistant metabolic alcalosis and systemic hypertension must always lead to the hypothesis of excess of mineralocorticoid action. It can be caused by excess of aldosterone production (aldosteronomas, primary adrenal hyperplasia, adrenocortical carcinoma) or by excess of mineralocorticoid action exerted by other substances, such as 11-deoxycortiscosterone (congenital adrenal hyperplasia) or cortisol (syndrome of apparent mineralocorticoid excess, glucocorticoid resistance and CS).
Although most of the effects of cortisol are mediated by the glucocorticoid receptor, cortisol can also bind to the mineralocorticoid receptor (MR). In physiological conditions, MR is protected from the action of cortisol by the conversion of cortisol to the inactive molecule cortisone, which is mediated by the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11BHSD2). In EAS, the extremely high ACTH and cortisol levels, such as those observed in this case, overwhelm inactivation of cortisol by the 11βHSD2 enzyme on the MR; thus resulting in aldosterone-like effects of cortisol in the kidney [7] . For this reason, in patients with confirmed or suspected neoplasm, the presence of excess of mineralocorticoid action should promptly point to the suspicion of EAS.
Once made the suspicion, the confirmation of the diagnosis of EAS requires a rigorous and sequential complementary evaluation, that includes: 1) esta-blishment of endogenous autonomous hypercortisolemia; 2) verification of ACTH dependency; 3) differentiation of the more common pituitary Cushing Disease; and 4) localization of the source of ACTH secretion [6, 7, 19] . In this patient, the presence of autonomous hypercortisolemia was confirmed by the absence of suppression of cortisol by dexametasone. The ACTH dependency was confirmed by the extremely high levels of morning serum ACTH. Cushing disease was excluded by absence of pituitary adenoma and by the confirmation of the source of ACTH secretion, demonstrated by the immunohistochemistry positivity for ACTH in the supraclavicular lymph node biopsy [1] .
Tumors manifested by EAS have been associated with reduced survival despite appropriate treatment, possibly due to complications such as sepsis, aortic dissection and gastrointestinal haemorrhage [4, 20] . Although the ideal treatment is excision of the tumor, drugs that help to control the effects of hypercortisolemia are important tools to reduce some of these complications. One or more drugs can be used, including ketoconazole, etomidate, mitotane, mifepristone, dopamine agonists, or the somatostatin analogs [21] [22] [23] . Reports of response to multikinase inhibitors, such as sorafenib, have also been published [20] . In our patient, the delay of the diagnosis and the hasty evolution to sepsis impaired the establishment of any specific treatment on time.
Therefore, the case reported is an opportunity to alert clinicians for the possibility of NDI being the first manifestation of severe hypercortisolemia, such as the observed in EAS.
